US 10125171
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
granted A61KA61K38/00A61K47/60
Quick answer
US patent 10125171 (Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof) held by Apellis Pharmaceuticals, Inc. expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/00, A61K47/60, A61K47/643, A61P